Lv12
70 积分 2023-09-15 加入
Loss of CDKN2A Enhances the Efficacy of Immunotherapy in EGFR Mutant Non-Small Cell Lung Cancer
22小时前
求助中
Understanding and targeting resistance mechanisms in NSCLC
1个月前
已完结
Sensitization of human Ewing's tumor cells to chemotherapy and heat treatment by the bioflavonoid quercetin
1个月前
已关闭
Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy
2个月前
已完结
Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management
2个月前
已完结
PD-L2 drives resistance to EGFR-TKIs: dynamic changes of the tumor immune environment and targeted therapy
4个月前
已完结
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF
7个月前
已完结
SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion
7个月前
已完结
SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion
8个月前
已完结
UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity
8个月前
已完结
皖公网安备34019202002308
